DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Tiadenol
Tiadenol
Cardiovascular Disease Dyslipidemia | Non-Pharmacologic Treatment |
Information to Users
Regulation of Pharmaceutical Prices: Evidence from a Reference Price Reform in Denmark
9719087.Pdf (3.190Mb)
Pharmaceutical Appendix to the Tariff Schedule 2
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
2 12/ 35 74Al
Anatomical Classification Guidelines V2020 EPHMRA ANATOMICAL
Information to Users
Review of Existing Classification Efforts
(12) Patent Application Publication (10) Pub. No.: US 2002/0155091A1 Huval Et Al
Trends in Lipid-Modifying Agent Use in 83 Countries
Subretinal Drusenoid Deposits in the Elderly in a Population-Based Study
Polyimidazoles for Use As Bile Acid Sequestrants
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Marrakesh Agreement Establishing the World Trade Organization
Anatomical Classification Guidelines V2018 EPHMRA ANATOMICAL
Dyslipidemia
Top View
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
DI(2-ETHYLHEXYL) PHTHALATE 1. Exposure Data
Nonpharmacologic Treatment of Dyslipidemia ⁎ Mark C
ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
Effects of Peroxisome Proliferators Gemfibrozil and Clofibrate on Syntheses of Dolichol and Cholesterol in Rat Liver
(12) United States Patent (10) Patent No.: US 6,365,186 B1 Huval Et Al
Customs Tariff - Schedule Xxi - 1
Peroxisome Proliferation Due to Di(2- Ethyihexyl) Phthalate (DEHP): Species Differences and Possible Mechanisms* by Clifford R
Medications, Dry Mouth and Dental Caries Among Older People: a Longitudinal Study
Regulation of Pharmaceutical Prices: Evidence from a Reference Price Reform in Denmark∗
Monitoring Expenditure and Utilisation of Medicinal Products in the European Union Countries: a Public Health Approach
Trends in Lipid-Modifying Agent Use in 83 Countries
Harmonized Tariff Schedule of the United States (2006) (Rev
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
(19) United States (12) Patent Application Publication (10) Pub
Resolution Ap (2000) 1
Regulation of Pharmaceutical Prices: Evidence from a Reference Price Reform in Denmark
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
Species Differences in the Hepatic